No. 1

Alternative drug pricing policies in the Americas

No. 2

The public and private circuits for the distribution of drugs in the Chilean health system

No. 3

Global comparative pharmaceutical expenditures

No. 4

Financing drugs in South-East Asia. Report of the first meeting of the WHO/SEARO Working Group on Drug Financing

No. 5

Public-private roles in the pharmaceutical sector. Implications for equitable access and rational drug use

No. 6

Health reform and drug financing. Selected topics

No. 7

Globalization and access to drugs. Perspectives on the WTO/TRIPS Agreement

No. 8

Financing drugs in South-East Asia. Report of the second meeting of the WHO/SEARO Working Group on Drug Financing

No. 9

Globalization, patents and drugs (1st ed.). An annotated bibliography

No. 10

Globalization, patents and drugs (2nd ed.). An annotated bibliography

No. 11

Network for monitoring the impact of globalization and TRIPS on access to medicines. Report of a meeting, February 2001, Bangkok, Thailand

No. 12

Implications of the Doha Declaration on the TRIPS Agreement and Public Health

No. 13

Cost-Containment Mechanisms for Essential Medicines, including Antiretrovirals, in China